Literature DB >> 10887568

[Validation of an ELISA for the measurement of human IgG against serogroup B Neisseria meningitidis protein].

X Ferriol Marchena1, A M García Malberti, R Ochoa Azze, I Bravo Verde, R Blanco González, E Estrada González, M Nerey Olivares, J C Martínez Rodríguez.   

Abstract

An indirect ELISA test was optimised in which B meningoccocus outer membrane proteins included in the Cuban Vaccine known as VA-MENGOC-BC were used as capture antigents. Specific antibodies in serum samples from vaccinated individuals were detected using a human anti-IgG conjugate, i.e. alklayne phosphatase, thus the reaction developed with a specific substrate called p-nitrophenilphophate. Standard serum was obtained from a reference standard, the gage curve range was 625 to 20,000/mL. The control serum was selected from the most interesting areas for the samples, hence, assay characteristics were determined. Intra-assay, inter-assay and total inaccuracies were lower than 10% in the most linear area of the curve. Detectability was 700/mL. Recovery, paralelism and linearity studies showed an under 10% inaccuracy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10887568

Source DB:  PubMed          Journal:  Rev Cubana Med Trop        ISSN: 0375-0760


  3 in total

1.  Standardization of Neisseria meningitidis serogroup B colorimetric serum bactericidal assay.

Authors:  Tamara Rodríguez; Miriam Lastre; Barbara Cedré; Judith del Campo; Gustavo Bracho; Caridad Zayas; Carlos Taboada; Miriam Díaz; Gustavo Sierra; Oliver Pérez
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

2.  New proteoliposome vaccine formulation from N. meningitidis serogroup B, without aluminum hydroxide, retains its antimeningococcal protectogenic potential as well as Th-1 adjuvant capacity.

Authors:  Beatriz Tamargo; Yanet Márquez; Wendy Ramírez; Bárbara Cedré; Manuel Fresno; Gustavo Sierra
Journal:  BMC Immunol       Date:  2013-02-25       Impact factor: 3.615

3.  Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B.

Authors:  Caridad Zayas; Domingo González; Reinaldo Acevedo; Judith del Campo; Miriam Lastre; Elizabeth González; Belkis Romeu; Maribel Cuello; Julio Balboa; Osmir Cabrera; Luisa Guilherme; Oliver Pérez
Journal:  BMC Immunol       Date:  2013-02-25       Impact factor: 3.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.